INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICIN
- 1 May 1978
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 311 (8072) , 1006-1009
- https://doi.org/10.1016/s0140-6736(78)90735-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Doxorubicin cardiotoxicity: possible role of digoxin in its prevention.BMJ, 1977
- Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinomaCancer, 1977
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United StatesCancer, 1977
- Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinomaCancer, 1976
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- Treatment of hepatocellular carcinoma with adriamycin.Preliminary communicationCancer, 1975
- Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage scheduleCancer, 1974
- Serum α-Feto Protein in Hepatoma Patients after Liver TransplantationGastroenterology, 1971